Adage Capital Partners Gp, L.L.C. Precigen, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Precigen, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 846,000 shares of PGEN stock, worth $3.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
846,000
Previous 11,276,000
92.5%
Holding current value
$3.9 Million
Previous $16 Million
82.62%
% of portfolio
0.0%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding PGEN
# of Institutions
187Shares Held
194MCall Options Held
6.61MPut Options Held
2.06M-
Third Security, LLC83.5MShares$385 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$122 Million4.02% of portfolio
-
Tang Capital Management LLC San Diego, CA12.4MShares$57.2 Million1.85% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.94MShares$41.2 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $960M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...